10.0.1.177

US science-focused venture capital firm Panorama Capital leads $21.5m Series A extension financing in Alvine Pharmaceuticals

280
Founder investors in the biopharmaceutical company include InterWest Partners, Prospect Venture Partners, Sofinnova Vent